A detailed history of Ameritas Investment Partners, Inc. transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 4,741 shares of LYRA stock, worth $853. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,741
Previous 4,741 -0.0%
Holding current value
$853
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.26 - $6.25 $1,232 - $29,631
4,741 New
4,741 $1,000
Q2 2021

Aug 06, 2021

SELL
$6.91 - $12.59 $2,508 - $4,570
-363 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$10.91 - $18.56 $3,960 - $6,737
363 New
363 $4,000

Others Institutions Holding LYRA

About Lyra Therapeutics, Inc.


  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.